DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 70 filers reported holding DICE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,746,500 | -43.0% | 410,000 | -37.9% | 1.68% | -30.3% |
| Q4 2022 | $20,592,000 | -6.4% | 660,000 | -39.2% | 2.41% | -10.9% |
| Q3 2022 | $22,009,000 | +43.9% | 1,085,251 | +10.1% | 2.71% | -3.5% |
| Q2 2022 | $15,291,000 | -42.3% | 985,251 | -28.9% | 2.80% | -18.4% |
| Q1 2022 | $26,500,000 | -37.1% | 1,385,251 | -16.8% | 3.44% | -20.9% |
| Q4 2021 | $42,122,000 | +10.9% | 1,664,251 | +43.4% | 4.34% | +58.5% |
| Q3 2021 | $37,998,000 | – | 1,160,251 | – | 2.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $102,737,575 | 55.73% |
| Sands Capital Ventures, LLC | 2,748,970 | $85,768 | 23.49% |
| OUP Management Co., LLC | 268,346 | $8,372,395 | 13.67% |
| New Leaf Venture Partners, L.L.C. | 371,693 | $11,596,822 | 8.40% |
| RA Capital Management | 6,848,911 | $213,686,023 | 4.33% |
| VR Adviser, LLC | 819,000 | $25,552,800 | 4.30% |
| SVB FINANCIAL GROUP | 42,358 | $1,321,570 | 3.61% |
| Logos Global Management LP | 660,000 | $20,592,000 | 2.41% |
| Deep Track Capital, LP | 1,734,143 | $54,105,262 | 2.27% |
| Samsara BioCapital, LLC | 202,773 | $6,326,518 | 1.36% |